Product
NrtIs
1 clinical trial
1 indication
Indication
Chronic Hepatitis BClinical trial
A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase InhibitorsStatus: Completed, Estimated PCD: 2022-12-05